532-24797-10392
5 vaccinations
16 coded responses
47 check-ins
14 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 201 / VA
- Registered
- 2021-01-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-22
Dose 1 — Moderna
-
2021-01-23
Registered in v-safe
-
2021-01-23
Survey response — days 1–6 daily, dose 1MedDRA: Chills, Fatigue, Headache — Feeling: Good · Site: Pain, Itching · Fatigue or tirednessFree text: Had chills and mild headache and fatigue yesterdayMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-24
Survey response — days 1–6 daily, dose 1MedDRA: Rhinorrhoea — Feeling: Good · Site: Pain, Itching · Fatigue or tirednessFree text: Mild runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-25
Survey response — days 1–6 daily, dose 1MedDRA: Adverse reaction — Feeling: Good · Site: Pain, Itching · Chills, Fatigue or tirednessFree text: All symptoms mild.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-26
- 2021-01-27
- 2021-01-28
- 2021-01-29
-
2021-02-05
Survey response — day 14, dose 1MedDRA: Injection site erythema, Injection site pain, Injection site pruritus — Feeling: GoodFree text: Redness and flush of upper arm at injection site. Increased pain and itching. Lasted for 2 days and started on day 8 after vaccine.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-12
Survey response — day 21, dose 1MedDRA: Abnormal dreams — Feeling: GoodFree text: Several vivid and weird dreams. I now recall that I have had the vivid dreams in the three weeks since receiving the vaccine. It has been notable.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-19
Dose 2 — Moderna
-
2021-02-19
Health check-in — day 0, dose 2Feeling: Good · Site: Pain · Fever · Headache, Fatigue or tirednessAdult check-in
-
2021-02-20
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Itching · Headache, Joint pains, Fatigue or tiredness, NauseaAdult check-in
- 2021-02-21
-
2021-02-22
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Itching · HeadacheAdult check-in
-
2021-02-23
Survey response — days 1–6 daily, dose 2MedDRA: Rash — Feeling: Good · Site: Itching · Rash, not including the immediate area around the injection siteFree text: Rash on abdomenMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-24
Survey response — days 1–6 daily, dose 2MedDRA: Injection site pruritus, Injection site swelling, Rash — Feeling: Good · Site: Itching · Rash, not including the immediate area around the injection siteFree text: Abdominal rash persists - itching and mild swelling at siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-25
Survey response — days 1–6 daily, dose 2MedDRA: Erythema, Pruritus, Rash — Feeling: Good · Rash, not including the immediate area around the injection siteFree text: Abdominal rash which is resolving - less redness and itching.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-26
Survey response — day 7, dose 2MedDRA: Rash — Feeling: Good · Rash, not including the immediate area around the injection siteFree text: Abdominal rash 95% resolved.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-11
- 2021-03-12
- 2021-03-19
- 2021-03-28
- 2021-04-02
-
2021-05-22
Survey response — 3 months, dose 2MedDRA: Arthralgia — Feeling: GoodFree text: Severe wrist pain - opposite arm to injection. Lasting one week.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-08-21
-
2021-10-04
Dose 3 — Moderna
- 2021-10-04
-
2021-10-05
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-10-06
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-10-07
Survey response — days 1–6 daily, dose 3MedDRA: Abnormal dreams — Feeling: Good · Fatigue or tirednessFree text: Very vivid dreams which have stayed with me in detail all day. Very bright and detailed including remembering singing an entire song in the dream.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-08
Survey response — days 1–6 daily, dose 3MedDRA: Eye pain, Respiratory tract congestion — Feeling: Fair · Fatigue or tirednessFree text: Pain behind eyes and head congestion.MedDRA releases: 2024-11 · check-in free text available
- 2021-10-09
- 2021-10-10
-
2021-10-11
Survey response — day 7, dose 3MedDRA: Rhinorrhoea — Feeling: GoodFree text: Runny nose for several days.MedDRA releases: 2024-11 · check-in free text available
- 2021-10-18
- 2021-10-25
- 2021-11-01
- 2021-11-14
- 2021-11-21
- 2022-01-03
- 2022-04-04
-
2022-05-04
Dose 4 — Moderna
- 2022-05-18
- 2022-05-25
- 2022-06-02
- 2022-06-08
-
2022-08-03
Survey response — 3 months, dose 4MedDRA: Decreased appetite, Dysgeusia, Fatigue, SARS-CoV-2 test positive — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Positive Covid test 1 week ago. Took Paxlovid and don't know the impact of that yet. Caused bitter taste in mouth and decreased appetite. Have fatigue which has been major symptom.MedDRA releases: 2024-11 · check-in free text available
- 2022-11-02
-
2022-12-13
Dose 5 — Moderna
-
2023-05-04
Survey response — 12 months, dose 4MedDRA: Fatigue, Nasopharyngitis, Productive cough, Respiratory tract congestion, SARS-CoV-2 test negative — Feeling: Good · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
-
2023-06-13
Survey response — 6 months, dose 5MedDRA: Exposure to SARS-CoV-2, Feeling abnormal, Respiratory tract infection viral, SARS-CoV-2 test negative — Feeling: Good · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-22 | Moderna | |
| 2 | 2021-02-19 | Moderna | |
| 3 | 2021-10-04 | Moderna | No |
| 4 | 2022-05-04 | Moderna | No |
| 5 | 2022-12-13 | Moderna | No |
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Had chills and mild headache and fatigue yesterday
Systemic reaction (other): Mild runny nose
Systemic reaction (other): All symptoms mild.
Release 3 — day 14, dose 1
Symptoms: Redness and flush of upper arm at injection site. Increased pain and itching. Lasted for 2 days and started on day 8 after vaccine.
Release 4 — day 21, dose 1
Symptoms: Several vivid and weird dreams. I now recall that I have had the vivid dreams in the three weeks since receiving the vaccine. It has been notable.
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Rash on abdomen
Systemic reaction (other): Abdominal rash persists - itching and mild swelling at site
Systemic reaction (other): Abdominal rash which is resolving - less redness and itching.
Release 4 — day 7, dose 2
Systemic reaction (other): Abdominal rash 95% resolved.
Release 8 — 3 months, dose 2
Symptoms: Severe wrist pain - opposite arm to injection. Lasting one week.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Very vivid dreams which have stayed with me in detail all day. Very bright and detailed including remembering singing an entire song in the dream.
Systemic reaction (other): Pain behind eyes and head congestion.
Release 10 — day 7, dose 3
Systemic reaction (other): Runny nose for several days.
Release 12 — 3 months, dose 4
Symptoms: Positive Covid test 1 week ago. Took Paxlovid and don't know the impact of that yet. Caused bitter taste in mouth and decreased appetite. Have fatigue which has been major symptom.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abnormal dreams | ✓ | ✓ | ✓ |
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Decreased appetite | · | · | ✓ |
| SD | Dysgeusia | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Feeling abnormal | · | · | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site pain | ✓ | ✓ | ✓ |
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Productive cough | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Respiratory tract infection viral | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Abnormal dreams | · | · | ✓ |
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
| SRO | Chills | ✓ | ✓ | ✓ |
| SRO | Erythema | ✓ | ✓ | ✓ |
| SRO | Eye pain | · | · | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Injection site pruritus | ✓ | ✓ | ✓ |
| SRO | Injection site swelling | ✓ | ✓ | ✓ |
| SRO | Pruritus | ✓ | ✓ | ✓ |
| SRO | Rash | ✓ | ✓ | ✓ |
| SRO | Respiratory tract congestion | · | · | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release